4
Changes in Ownership
Spyre Therapeutics, Inc. Filed Acc 0000950170-23-073904
Director disposed of 3,435,480 shares (other)
- Director acquired 812,076 shares (other)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Fairmount Funds Management LLC · Director
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2023-12-29 | Other disposition : show line 1 in the form 10b5-1 | −3,435,480 | 0 | I |
| 2023-12-29 | Other acquisition : show line 2 in the form 10b5-1 | +406,038 | 406,038 | I |
| 2023-12-29 | Other acquisition : show line 3 in the form 10b5-1 | +406,038 | 406,038 | I |
Loading xslF345X05/ownership.xml…